CNS Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Feb 24 | BuyUS$50,000 | John Climaco | Individual | 166,666 | US$0.30 | |
01 Feb 24 | BuyUS$20,000 | Christopher Downs | Individual | 66,666 | US$0.30 | |
01 Feb 24 | BuyUS$10,000 | Jerzy Gumulka | Individual | 33,333 | US$0.30 | |
01 Feb 24 | BuyUS$10,000 | Carl Evans | Individual | 33,333 | US$0.30 | |
22 Aug 23 | BuyUS$34,177 | Christopher Downs | Individual | 27,000 | US$1.27 | |
16 Aug 23 | BuyUS$4,945 | John Climaco | Individual | 2,750 | US$1.80 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 10,642 | 0.1% |
Institutions | 249,616 | 2.35% |
Hedge Funds | 676,203 | 6.36% |
Individual Insiders | 1,001,136 | 9.41% |
General Public | 8,697,335 | 81.8% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 377.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
676,203 | US$147.4k | 0% | no data | |||
575,525 | US$125.5k | 736% | no data | |||
251,562 | US$54.8k | 414% | no data | |||
115,625 | US$25.2k | 640% | no data | |||
90,332 | US$19.7k | 80.7% | no data | |||
58,369 | US$12.7k | 146% | no data | |||
33,458 | US$7.3k | 450% | no data | |||
24,436 | US$5.3k | 0% | no data | |||
22,556 | US$4.9k | 0% | no data | |||
19,084 | US$4.2k | 0% | no data | |||
13,152 | US$2.9k | 0% | no data | |||
11,144 | US$2.4k | 0% | no data | |||
10,002 | US$2.2k | 0% | no data | |||
8,553 | US$1.9k | 16.1% | no data | |||
6,667 | US$1.5k | 0% | no data | |||
6,323 | US$1.4k | 0% | no data | |||
5,953 | US$1.3k | 0% | no data | |||
3,975 | US$866.6 | -16.1% | no data | |||
2,086 | US$454.6 | 201% | no data | |||
1,361 | US$296.8 | 16.6% | no data | |||
690 | US$150.5 | 0% | no data | |||
212 | US$46.1 | 0% | no data | |||
175 | US$38.3 | -63.2% | no data | |||
67 | US$14.6 | 0% | no data | |||
53 | US$11.6 | 0% | no data |